|
|
|
| Analysis of the Development Trends of Life and Health Sciences and Technology |
Li XU,Ruonan YANG,Yue WANG,Huilin SHI,Zhenqi LI,Chenqi JIN,Wei LI,Ping XU**( ) |
| Shanghai Information Center for Life Sciences, Shanghai Institute of Nutrition and Health,Chinese Academy of Sciences, Shanghai 200031, China |
|
|
|
Abstract Life and health sciences and technology is one of the key areas that are most expected to achieve revolutionary breakthroughs in the new round of scientific and technological revolution and industrial transformation. Through the convergence and integration of disciplines and technologies, it has shown a new development trend, givenrise to new disciplines, new directions, and new frontiers, and created new subdivisions and growth points in the industry. In recent years, innovation in the field of life and health sciences and technology has been active, and major achievements in frontier areas such as gene editing, synthetic biology, life omics, regenerative medicine, and organoids have been intensively developed. Based on the in-depth analysis of the current development trends and frontier directions in the field of life and health sciences and technology, its future development prospects are discussed and the key layout direction is proposed to provide reference for the development of life and health sciences and technology innovation.
|
|
Received: 26 December 2023
Published: 04 February 2024
|
|
|
|
|
| [1] |
Nurk S, Koren S, Rhie A, et al. The complete sequence of a human genome. Science, 2022, 376(6588): 44-53.
doi: 10.1126/science.abj6987
pmid: 35357919
|
|
|
| [2] |
Hallast P, Ebert P, Loftus M, et al. Assembly of 43 human Y chromosomes reveals extensive complexity and variation. Nature, 2023, 621(7978): 355-364.
doi: 10.1038/s41586-023-06425-6
|
|
|
| [3] |
Liao W W, Asri M, Ebler J, et al. A draft human pangenome reference. Nature, 2023, 617(7960): 312-324.
doi: 10.1038/s41586-023-05896-x
|
|
|
| [4] |
Brinkerhoff H, Kang A S W, Liu J Q, et al. Multiple rereads of single proteins at single-amino acid resolution using nanopores. Science, 2021, 374(6574): 1509-1513.
doi: 10.1126/science.abl4381
|
|
|
| [5] |
Wang K F, Zhang S Y, Zhou X, et al. Unambiguous discrimination of all 20 proteinogenic amino acids and their modifications by nanopore. Nature Methods, 2023, DOI: 10.1038/s41592-023-02021-8.
doi: 10.1038/s41592-023-02021-8
|
|
|
| [6] |
Mund A, Coscia F, Kriston A, et al. Deep Visual Proteomics defines single-cell identity and heterogeneity. Nature Biotechnology, 2022, 40(8): 1231-1240.
doi: 10.1038/s41587-022-01302-5
pmid: 35590073
|
|
|
| [7] |
Rappez L, Stadler M, Triana S, et al. SpaceM reveals metabolic states of single cells. Nature Methods, 2021, 18(7): 799-805.
doi: 10.1038/s41592-021-01198-0
pmid: 34226721
|
|
|
| [8] |
Deng Y X, Bartosovic M, Kukanja P, et al. Spatial-CUT&Tag: spatially resolved chromatin modification profiling at the cellular level. Science, 2022, 375(6581): 681-686.
doi: 10.1126/science.abg7216
|
|
|
| [9] |
Deng Y X, Bartosovic M, Ma S, et al. Spatial profiling of chromatin accessibility in mouse and human tissues. Nature, 2022, 609(7926): 375-383.
doi: 10.1038/s41586-022-05094-1
|
|
|
| [10] |
Payne A C, Chiang Z D, Reginato P L, et al. In situ genome sequencing resolves DNA sequence and structure in intact biological samples. Science, 2021, 371(6532): eaay3446.
doi: 10.1126/science.aay3446
|
|
|
| [11] |
Zhang D, Deng Y X, Kukanja P, et al. Spatial epigenome-transcriptome co-profiling of mammalian tissues. Nature, 2023, 616(7955): 113-122.
doi: 10.1038/s41586-023-05795-1
|
|
|
| [12] |
Vicari M, Mirzazadeh R, Nilsson A, et al. Spatial multimodal analysis of transcriptomes and metabolomes in tissues. Nature Biotechnology, 2023, DOI: 10.1038/s41587-023-01937-y.
doi: 10.1038/s41587-023-01937-y
|
|
|
| [13] |
Ben-Chetrit N, Niu X, Swett A D, et al. Integration of whole transcriptome spatial profiling with protein markers. Nature Biotechnology, 2023, 41(6): 788-793.
doi: 10.1038/s41587-022-01536-3
pmid: 36593397
|
|
|
| [14] |
Wolf J, Rasmussen D K, Sun Y J, et al. Liquid-biopsy proteomics combined with AI identifies cellular drivers of eye aging and disease in vivo. Cell, 2023, 186(22): 4868-4884, e12.
doi: 10.1016/j.cell.2023.09.012
|
|
|
| [15] |
Vermeulen C, Pagès-Gallego M, Kester L, et al. Ultra-fast deep-learned CNS tumour classification during surgery. Nature, 2023, 622(7984): 842-849.
doi: 10.1038/s41586-023-06615-2
|
|
|
| [16] |
Allesøe R L, Lundgaard A T, Hernández Medina R, et al. Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models. Nature Biotechnology, 2023, 41(3): 399-408.
doi: 10.1038/s41587-022-01520-x
pmid: 36593394
|
|
|
| [17] |
Li J M, Xiong M Z, Fu X H, et al. Determining a multimodal aging clock in a cohort of Chinese women. Med, 2023, 4(11): 825-848, e13.
doi: 10.1016/j.medj.2023.06.010
|
|
|
| [18] |
Shalon D, Culver R N, Grembi J A, et al. Profiling the human intestinal environment under physiological conditions. Nature, 2023, 617(7961): 581-591.
doi: 10.1038/s41586-023-05989-7
|
|
|
| [19] |
Thuronyi B W, Koblan L W, Levy J M, et al. Continuous evolution of base editors with expanded target compatibility and improved activity. Nature Biotechnology, 2019, 37(9): 1070-1079.
doi: 10.1038/s41587-019-0193-0
pmid: 31332326
|
|
|
| [20] |
Gaudelli N M, Komor A C, Rees H A, et al. Programmable base editing of AoT to GoC in genomic DNA without DNA cleavage. Nature, 2017, 551(7681): 464-471.
doi: 10.1038/nature24644
|
|
|
| [21] |
Cox D B T, Gootenberg J S, Abudayyeh O O, et al. RNA editing with CRISPR-Cas13. Science, 2017, 358(6366): 1019-1027.
doi: 10.1126/science.aaq0180
pmid: 29070703
|
|
|
| [22] |
Abudayyeh O O, Gootenberg J S, Franklin B, et al. A cytosine deaminase for programmable single-base RNA editing. Science, 2019, 365(6451): 382-386.
doi: 10.1126/science.aax7063
pmid: 31296651
|
|
|
| [23] |
Jiang T T, Zhang X O, Weng Z P, et al. Deletion and replacement of long genomic sequences using prime editing. Nature Biotechnology, 2022, 40(2): 227-234.
doi: 10.1038/s41587-021-01026-y
|
|
|
| [24] |
Choi J, Chen W, Suiter C C, et al. Precise genomic deletions using paired prime editing. Nature Biotechnology, 2022, 40(2): 218-226.
doi: 10.1038/s41587-021-01025-z
|
|
|
| [25] |
Yuan Q C, Gao X. Multiplex base- and prime-editing with drive-and-process CRISPR arrays. Nature Communications, 2022, 13(1): 2771.
doi: 10.1038/s41467-022-30514-1
pmid: 35589728
|
|
|
| [26] |
Anzalone A V, Gao X D, Podracky C J, et al. Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing. Nature Biotechnology, 2022, 40(5): 731-740.
doi: 10.1038/s41587-021-01133-w
|
|
|
| [27] |
Vertex. Vertex and CRISPR therapeutics announce authorization of the first CRISPR/Cas9 gene-edited therapy, CASGEVYTM (exagamglogene autotemcel), by the United Kingdom MHRA for the treatment of sickle cell disease and transfusion-dependent beta thalassemia. [2023-11-16]. https://news.vrtx.com/news-releases/news-release-details/vertex-and-crispr-therapeutics-announce-authorization-first.
|
|
|
| [28] |
Thi Nhu Thao T, Labroussaa F, Ebert N, et al. Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform. Nature, 2020, 582(7813): 561-565.
doi: 10.1038/s41586-020-2294-9
|
|
|
| [29] |
Hsieh C L, Goldsmith J A, Schaub J M, et al. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes. Science, 2020, 369(6510): 1501-1505.
doi: 10.1126/science.abd0826
|
|
|
| [30] |
Cao L X, Goreshnik I, Coventry B, et al. De novo design of picomolar SARS-CoV-2 miniprotein inhibitors. Science, 2020, 370(6515): 426-431.
doi: 10.1126/science.abd9909
|
|
|
| [31] |
Stokes J M, Yang K, Swanson K, et al. A deep learning approach to antibiotic discovery. Cell, 2020, 180(4): 688-702, e13.
doi: S0092-8674(20)30102-1
pmid: 32084340
|
|
|
| [32] |
Liu G, Catacutan D B, Rathod K, et al. Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii. Nature Chemical Biology, 2023, 19(11): 1342-1350.
doi: 10.1038/s41589-023-01349-8
|
|
|
| [33] |
Hie B L, Shanker V R, Xu D, et al. Efficient evolution of human antibodies from general protein language models. Nature Biotechnology, 2023,DOI: 10.1038/s41587-023-01763-2.
doi: 10.1038/s41587-023-01763-2
|
|
|
| [34] |
Quijano-Rubio A, Yeh H W, Park J, et al. De novo design of modular and tunable protein biosensors. Nature, 2021, 591(7850): 482-487.
doi: 10.1038/s41586-021-03258-z
|
|
|
| [35] |
Herud-Sikimić O, Stiel A C, Kolb M, et al. A biosensor for the direct visualization of auxin. Nature, 2021, 592(7856): 768-772.
doi: 10.1038/s41586-021-03425-2
|
|
|
| [36] |
Srinivasan P, Smolke C D. Biosynthesis of medicinal tropane alkaloids in yeast. Nature, 2020, 585(7826): 614-619.
doi: 10.1038/s41586-020-2650-9
|
|
|
| [37] |
Zhang J, Hansen L G, Gudich O, et al. A microbial supply chain for production of the anti-cancer drug vinblastine. Nature, 2022, 609(7926): 341-347.
doi: 10.1038/s41586-022-05157-3
|
|
|
| [38] |
Jan M, Scarfò I, Larson R C, et al. Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide. Science Translational Medicine, 2021, 13(575): eabb6295.
doi: 10.1126/scitranslmed.abb6295
|
|
|
| [39] |
Hernandez-Lopez R A, Yu W, Cabral K A, et al. T cell circuits that sense antigen density with an ultrasensitive threshold. Science, 2021, 371(6534): 1166-1171.
doi: 10.1126/science.abc1855
pmid: 33632893
|
|
|
| [40] |
Kreitz J, Friedrich M J, Guru A, et al. Programmable protein delivery with a bacterial contractile injection system. Nature, 2023, 616(7956): 357-364.
doi: 10.1038/s41586-023-05870-7
|
|
|
| [41] |
Canale F P, Basso C, Antonini G, et al. Metabolic modulation of tumours with engineered bacteria for immunotherapy. Nature, 2021, 598(7882): 662-666.
doi: 10.1038/s41586-021-04003-2
|
|
|
| [42] |
Nick J A, Dedrick R M, Gray A L, et al. Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection. Cell, 2022, 185(11): 1860-1874, e12.
doi: 10.1016/j.cell.2022.04.024
|
|
|
| [43] |
Chen Y E, Bousbaine D, Veinbachs A, et al. Engineered skin bacteria induce antitumor T cell responses against melanoma. Science, 2023, 380(6641): 203-210.
doi: 10.1126/science.abp9563
pmid: 37053311
|
|
|
| [44] |
Lin Z M, Akin H, Rao R, et al. Evolutionary-scale prediction of atomic-level protein structure with a language model. Science, 2023, 379(6637): 1123-1130.
doi: 10.1126/science.ade2574
pmid: 36927031
|
|
|
| [45] |
Bileschi M L, Belanger D, Bryant D H, et al. Using deep learning to annotate the protein universe. Nature Biotechnology, 2022, 40(6): 932-937.
doi: 10.1038/s41587-021-01179-w
|
|
|
| [46] |
Belanger D, Colwell L J. Hallucinating functional protein sequences. Nature Biotechnology, 2023, 41(8): 1073-1074.
doi: 10.1038/s41587-022-01634-2
|
|
|
| [47] |
Rives A, Meier J, Sercu T, et al. Biological structure and function emerge from scaling unsupervised learning to 250 million protein sequences. Proceedings of the National Academy of Sciences of the United States of America, 2021, 118(15): e2016239118.
|
|
|
| [48] |
Dauparas J, Anishchenko I, Bennett N, et al. Robust deep learning-based protein sequence design using ProteinMPNN. Science, 2022, 378(6615): 49-56.
doi: 10.1126/science.add2187
pmid: 36108050
|
|
|
| [49] |
Wang J, Lisanza S, Juergens D, et al. Scaffolding protein functional sites using deep learning. Science, 2022, 377(6604): 387-394.
doi: 10.1126/science.abn2100
pmid: 35862514
|
|
|
| [50] |
Wicky B I M, Milles L F, Courbet A, et al. Hallucinating symmetric protein assemblies. Science, 2022, 378(6615): 56-61.
doi: 10.1126/science.add1964
pmid: 36108048
|
|
|
| [51] |
FDA. Artificial intelligence and machine learning (AI/ML)-enabled medical devices. [2023-10-19]. https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices?utm_medium=email&utm_source=govdelivery#resources.
|
|
|
| [52] |
Bouffi C, Wikenheiser-Brokamp K A, Chaturvedi P, et al. In vivo development of immune tissue in human intestinal organoids transplanted into humanized mice. Nature Biotechnology, 2023, 41(6): 824-831.
doi: 10.1038/s41587-022-01558-x
pmid: 36702898
|
|
|
| [53] |
Gabriel E, Albanna W, Pasquini G, et al. Human brain organoids assemble functionally integrated bilateral optic vesicles. Cell Stem Cell, 2021, 28(10): 1740-1757, e8.
doi: 10.1016/j.stem.2021.07.010
pmid: 34407456
|
|
|
| [54] |
Amadei G, Handford C E, Qiu C X, et al. Embryomodel completes gastrulation to neurulation and organogenesis. Nature, 2022, 610(7930): 143-153.
doi: 10.1038/s41586-022-05246-3
|
|
|
| [55] |
Esfahani M S, Hamilton E G, Mehrmohamadi M, et al. Inferring gene expression from cell-free DNA fragmentation profiles. Nature Biotechnology, 2022, 40(4): 585-597.
doi: 10.1038/s41587-022-01222-4
pmid: 35361996
|
|
|
| [56] |
Fedyuk V, Erez N, Furth N, et al. Multiplexed, single-molecule, epigenetic analysis of plasma-isolated nucleosomes for cancer diagnostics. Nature Biotechnology, 2023, 41(2): 212-221.
doi: 10.1038/s41587-022-01447-3
|
|
|
| [57] |
Mougiakakos D, Krönke G, Völkl S, et al. CD19-targeted CAR T cells in refractory systemic lupus erythematosus. The New England Journal of Medicine, 2021, 385(6): 567-569.
doi: 10.1056/NEJMc2107725
pmid: 34347960
|
|
|
| [58] |
Amor C, Feucht J, Leibold J, et al. Senolytic CAR T cells reverse senescence-associated pathologies. Nature, 2020, 583(7814): 127-132.
doi: 10.1038/s41586-020-2403-9
|
|
|
| [59] |
Rurik J G, Tombácz I, Yadegari A, et al. CAR T cells produced in vivo to treat cardiac injury. Science, 2022, 375(6576): 91-96.
doi: 10.1126/science.abm0594
pmid: 34990237
|
|
|
| [60] |
Williams J Z, Allen G M, Shah D, et al. Precise T cell recognition programs designed by transcriptionally linking multiple receptors. Science, 2020, 370(6520): 1099-1104.
doi: 10.1126/science.abc6270
pmid: 33243890
|
|
|
| [61] |
Lajoie M J, Boyken S E, Salter A I, et al. Designed protein logic to target cells with precise combinations of surface antigens. Science, 2020, 369(6511): 1637-1643.
doi: 10.1126/science.aba6527
pmid: 32820060
|
|
|
| [62] |
Tousley A M, Rotiroti M C, Labanieh L, et al. Co-opting signalling molecules enables logic-gated control of CAR T cells. Nature, 2023, 615(7952): 507-516.
doi: 10.1038/s41586-023-05778-2
|
|
|
| [63] |
Balboa D, Barsby T, Lithovius V, et al. Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells. Nature Biotechnology, 2022, 40(7): 1042-1055.
doi: 10.1038/s41587-022-01219-z
pmid: 35241836
|
|
|
| [64] |
Baloh R H, Johnson J P, Avalos P, et al. Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1/2a trial. Nature Medicine, 2022, 28(9): 1813-1822.
doi: 10.1038/s41591-022-01956-3
pmid: 36064599
|
|
|
| [65] |
Fumagalli F, Calbi V, Sora M G N, et al. Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/ 2 trial and expanded access. Lancet, 2022, 399(10322): 372-383.
doi: 10.1016/S0140-6736(21)02017-1
|
|
|
| [66] |
Dolgin E. Diabetes cell therapies take evasive action. Nature Biotechnology, 2022, 40(3): 291-295.
doi: 10.1038/s41587-022-01246-w
|
|
|
| [67] |
Qiu Y C, O’Neill N, Maffei B, et al. On-demand cell-autonomous gene therapy for brain circuit disorders. Science, 2022, 378(6619): 523-532.
doi: 10.1126/science.abq6656
pmid: 36378958
|
|
|
| [68] |
Chen Y F, Hong Z X, Wang J Y, et al. Circuit-specific gene therapy reverses core symptoms in a primate Parkinson’s disease model. Cell, 2023, 186(24): 5394-5410, e18.
doi: 10.1016/j.cell.2023.10.004
|
|
|
| [69] |
Squair J W, Milano M, de Coucy A, et al. Recovery of walking after paralysis by regenerating characterized neurons to their natural target region. Science, 2023, 381(6664): 1338-1345.
doi: 10.1126/science.adi6412
pmid: 37733871
|
|
|
| [70] |
Intellia Therapeutics. Intellia therapeutics announces FDA clearance of investigational new drug (IND) application to initiate a pivotal phase 3 trial of NTLA-2001 for the treatment of transthyretin (ATTR) amyloidosis with cardiomyopathy. [2023-10-18]. https://www.intelliatx.com/our-pipeline.
|
|
|
| [71] |
Desai A S, Webb D J, Taubel J, et al. Zilebesiran, an RNA interference therapeutic agent for hypertension. The New England Journal of Medicine, 2023, 389(3): 228-238.
doi: 10.1056/NEJMoa2208391
pmid: 37467498
|
|
|
| [72] |
Mummery C J, Börjesson-Hanson A, Blackburn D J, et al. Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial. Nature Medicine, 2023, 29(6): 1437-1447.
doi: 10.1038/s41591-023-02326-3
|
|
|
| [73] |
Park J S, Gazzaniga F S, Wu M, et al. Targeting PD-L2-RGMb overcomes microbiome-related immunotherapy resistance. Nature, 2023, 617(7960): 377-385.
doi: 10.1038/s41586-023-06026-3
|
|
|
| [74] |
Diwakar D, Dzutsev Amiran K, McCulloch John A, et al. Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients. Science, 2021, 371(6529): 595-602.
doi: 10.1126/science.abf3363
pmid: 33542131
|
|
|
| [75] |
Baruch E N, Youngster I, Ben-Betzalel G, et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science, 2021, 371(6529): 602-609.
doi: 10.1126/science.abb5920
pmid: 33303685
|
|
|
| [76] |
Routy B, Lenehan J G, Miller W H Jr, et al. Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial. Nature Medicine, 2023, 29(8): 2121-2132.
doi: 10.1038/s41591-023-02453-x
pmid: 37414899
|
|
|
| [77] |
Zhao W S, Lei J, Ke S B, et al. Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215). eClinicalMedicine, 2023, 66: 102315.
doi: 10.1016/j.eclinm.2023.102315
|
|
|
| [78] |
Federici S, Kredo-Russo S, Valdés-Mas R, et al. Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation. Cell, 2022, 185(16): 2879-2898.e24.
doi: 10.1016/j.cell.2022.07.003
pmid: 35931020
|
|
|
| [79] |
Ichikawa M, Nakamoto N, Kredo-Russo S, et al. Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitis. Nature Communications, 2023, 14(1): 3261.
doi: 10.1038/s41467-023-39029-9
|
|
|
| [80] |
Kviatcovsky D, Valdés-Mas R, Federici S, et al. Phage therapy in noncommunicable diseases. Science, 2023, 382(6668): 266-267.
doi: 10.1126/science.adh2718
pmid: 37856612
|
|
|
| [81] |
Ni Y Q, Qian L L, Siliceo S L, et al. Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations. Cell Metabolism, 2023, 35(9): 1530-1547, e8.
doi: 10.1016/j.cmet.2023.08.002
pmid: 37673036
|
|
|
| [82] |
Chen R Y, Mostafa I, Hibberd M C, et al. A microbiota-directed food intervention for undernourished children. The New England Journal of Medicine, 2021, 384(16): 1517-1528.
doi: 10.1056/NEJMoa2023294
pmid: 33826814
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
